Albemarle Co. (NYSE:ALB) Forecasted to Post FY2025 Earnings of $9.48 Per Share

Albemarle Co. (NYSE:ALB) – Equities research analysts at Scotiabank lifted their FY2025 earnings per share estimates for Albemarle in a research note issued on Monday, May 6th. Scotiabank analyst B. Isaacson now forecasts that the specialty chemicals company will post earnings of $9.48 per share for the year, up from their prior forecast of $9.30. Scotiabank currently has a “Sector Outperform” rating and a $150.00 price objective on the stock. The consensus estimate for Albemarle’s current full-year earnings is $2.86 per share.

Several other brokerages also recently weighed in on ALB. Oppenheimer lowered their target price on Albemarle from $191.00 to $188.00 and set an “outperform” rating for the company in a research note on Friday, February 16th. TD Cowen downgraded Albemarle from an “outperform” rating to a “market perform” rating and dropped their price objective for the stock from $220.00 to $130.00 in a report on Monday, January 29th. Wells Fargo & Company increased their target price on Albemarle from $135.00 to $145.00 and gave the company an “overweight” rating in a research note on Thursday, April 11th. Vertical Research lowered shares of Albemarle from a “buy” rating to a “hold” rating and set a $145.00 price target for the company. in a research note on Friday, March 8th. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on shares of Albemarle from $125.00 to $140.00 and gave the company a “hold” rating in a research note on Tuesday. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $172.05.

Albemarle Price Performance

ALB opened at $133.55 on Wednesday. Albemarle has a twelve month low of $106.69 and a twelve month high of $247.44. The company has a current ratio of 2.84, a quick ratio of 1.91 and a debt-to-equity ratio of 0.37. The firm has a market cap of $15.70 billion, a price-to-earnings ratio of 48.56, a PEG ratio of 2.80 and a beta of 1.65. The company has a fifty day simple moving average of $123.39 and a 200 day simple moving average of $125.99.

Albemarle (NYSE:ALB) last released its quarterly earnings results on Thursday, May 2nd. The specialty chemicals company reported $0.26 earnings per share for the quarter, missing analysts’ consensus estimates of $0.35 by ($0.09). The company had revenue of $1.36 billion during the quarter, compared to analysts’ expectations of $1.29 billion. Albemarle had a return on equity of 14.53% and a net margin of 4.02%. The firm’s revenue was down 47.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned $10.32 EPS.

Albemarle Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, July 1st. Stockholders of record on Friday, June 14th will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 1.20%. The ex-dividend date is Friday, June 14th. Albemarle’s dividend payout ratio (DPR) is 58.18%.

Hedge Funds Weigh In On Albemarle

Several institutional investors have recently modified their holdings of ALB. Assetmark Inc. acquired a new position in Albemarle during the 3rd quarter valued at about $25,000. WFA Asset Management Corp acquired a new position in shares of Albemarle during the first quarter worth approximately $25,000. USCF Advisers LLC grew its holdings in Albemarle by 100.0% in the 4th quarter. USCF Advisers LLC now owns 200 shares of the specialty chemicals company’s stock worth $29,000 after buying an additional 100 shares in the last quarter. Arlington Trust Co LLC acquired a new stake in Albemarle in the 4th quarter valued at approximately $30,000. Finally, Tyler Stone Wealth Management bought a new stake in Albemarle during the 3rd quarter valued at $35,000. Institutional investors own 92.87% of the company’s stock.

Albemarle Company Profile

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.